富士製薬工業(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証PRM | 医薬品 | 4554/E00975 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2014/01/24 | 日証協 | 94,987株 | -5.11% | 10,487株 | +83.98% | 94,576株 | -8.16% | 26,901株 | +5.08% |
| 2014/01/17 | 日証協 | 100,101株 | -4.03% | 5,700株 | +119.23% | 102,977株 | -3.2% | 25,600株 | +115.13% |
| 2014/01/10 | 日証協 | 104,301株 | +0.97% | 2,600株 | +225% | 106,377株 | -0.84% | 11,900株 | +9999.99% |
| 2013/12/30 | 日証協 | 103,301株 | -0.29% | 800株 | -91.49% | 107,277株 | +3.47% | 100株 | -98.61% |
| 2013/12/27 | 日証協 | 103,601株 | -3.81% | 9,401株 | +141.05% | 103,677株 | -4.25% | 7,201株 | +454.35% |
| 2013/12/20 | 日証協 | 107,700株 | -0.37% | 3,900株 | -67.23% | 108,276株 | +0.19% | 1,299株 | -84.16% |
| 2013/12/13 | 日証協 | 108,100株 | -0.46% | 11,900株 | -26.54% | 108,076株 | -0.64% | 8,200株 | +6.49% |
| 2013/12/06 | 日証協 | 108,600株 | 0% | 16,200株 | -58.88% | 108,776株 | 0% | 7,700株 | -30.63% |
| 2013/11/29 | 日証協 | 108,600株 | -5.4% | 39,400株 | +8.54% | 108,776株 | +0.83% | 11,100株 | +21.98% |
| 2013/11/22 | 日証協 | 114,800株 | -5.44% | 36,299株 | -28.12% | 107,876株 | -2.79% | 9,100株 | -9% |
| 2013/11/15 | 日証協 | 121,401株 | +0.25% | 50,501株 | +50.75% | 110,976株 | -2.81% | 10,000株 | +56.25% |
| 2013/11/08 | 日証協 | 121,101株 | +11.42% | 33,500株 | -13.88% | 114,182株 | +2.25% | 6,400株 | -68% |
| 2013/11/01 | 日証協 | 108,690株 | +15.52% | 38,900株 | +455.71% | 111,671株 | -2.1% | 20,000株 | +73.91% |
| 2013/10/25 | 日証協 | 94,090株 | +2.17% | 7,000株 | -59.07% | 114,071株 | -0.35% | 11,500株 | -39.79% |
| 2013/10/18 | 日証協 | 92,090株 | +12.46% | 17,101株 | +67.82% | 114,471株 | +7.92% | 19,100株 | -1.94% |
| 2013/10/11 | 日証協 | 81,890株 | +11.82% | 10,190株 | -40.66% | 106,071株 | +10.37% | 19,478株 | +1.32% |
| 2013/10/04 | 日証協 | 73,237株 | +11.81% | 17,172株 | -41.59% | 96,107株 | +9.74% | 19,225株 | -40.16% |
| 2013/09/27 | 日証協 | 65,501株 | +12.74% | 29,400株 | -39.13% | 87,575株 | +20.83% | 32,128株 | +174.57% |
| 2013/09/20 | 日証協 | 58,101株 | +17.61% | 48,301株 | +21.05% | 72,476株 | +16.94% | 11,701株 | -29.08% |
※株式分割は考慮していませんのでご注意ください。
Page Top